Kincell Bio
Research Triangle Park, NC
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
56.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (7)
○ EMA GMP
○ MHRA GMP
Quick Facts: Kincell Bio
- Signal Score
- 56.5/100 (as of 2026-04-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Research Triangle Park, NC
- Modalities
- Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Kincell Bio
Cell therapy CDMO in Wisconsin.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
53.0
1 manufacturing site: Madison, WI
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Sites: Madison, WI
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press7 articles
1 manufacturing site: Madison, WI
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Recent News 7 articles
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - BioSpace
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs BioSpace
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - Business Wire
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs Business Wire
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - Voice of Alexandria
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs Voice of Alexandria
Kincell Bio Expands Research Triangle Park, North Carolina Facility - Contract Pharma
Kincell Bio Expands Research Triangle Park, North Carolina Facility Contract Pharma
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - Times Argus
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs Times Argus
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - News-Press NOW
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs News-Press NOW
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs - Yahoo Finance
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs Yahoo Finance
Frequently Asked Questions About Kincell Bio
What is Kincell Bio's CDMO Signal Score?
Kincell Bio has a Signal Score of 56/100, based on quality, operations, financial stability, and capacity data.
Evaluating Kincell Bio for a manufacturing program?
Use the free AI matchmaker to compare Kincell Bio against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
bluebird bio Manufacturing
Durham, NC
Signal Score: 78.5
Lentiviral, Cell Therapy
National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
Signal Score: 73.4
mRNA, Gene Therapy, Cell Therapy, Lentiviral
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 90.8
CAR-T, Cell Therapy
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 83.8
CAR-T, Cell Therapy